trending Market Intelligence /marketintelligence/en/news-insights/trending/hviya3qq_sy1OPkGGWGAfQ2 content esgSubNav
In This List

Sun Pharma recalls children's allergy drug from US, Puerto Rico markets

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Sun Pharma recalls children's allergy drug from US, Puerto Rico markets

Sun Pharmaceutical Industries Ltd.'s U.S. arm is recalling 13,200 bottles of children's cetirizine hydrochloride chewable tablets from the U.S. and Puerto Rico markets, according to an enforcement report by the U.S. FDA.

The ongoing class III recall by Sun Pharmaceutical Industries Inc. is for the 5 mg tablets, made at the company's Halol plant in Gujarat, India, because of failed tablet/capsule specifications.

The tablets are used for preventing or treating certain symptoms of hay fever and other upper respiratory allergies.